MMedication Read More FDA approves Colorado’s plan to import cheaper drugs from CanadaJune 21, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
WWildlife Read More Why we should vaccinate wild animalsJune 17, 2026 The Coyote Getter, invented in the 1930s, was a hunting device that spewed cyanide into the mouth of…
HHealth care Read More Centene to offer buyouts to some employeesJune 15, 2026 Sheldon Cooper | Lightrocket | Getty Images Centene said it offered buyouts to some employees on Monday, as…
HHealth care Read More New proposal would close Medicare drug price negotiation loopholeJune 14, 2026 WASHINGTON — The Trump administration on Friday proposed to change a policy that is designed to prevent drugmakers…
HHealth care Read More Prometheus, Lilly, Nvidia, Abridge, Luvelta: Readout NewsletterJune 12, 2026 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
HHealth Read More First Human Receives Experimental Therapy to Reverse Cellular AgingJune 10, 2026 Buckle up. High-stakes human testing has now begun on a gene therapy that promises to reverse aging at…
BBusiness Read More Weight loss drug maker stock sinks 25% as safety data spooks investorsJune 8, 2026 Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
BBusiness Read More Lilly shares safety, tolerability data on its next-gen obesity drugJune 7, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
HHealth Read More Revolution Medicines’ pancreatic cancer drug proving hard to getJune 5, 2026 Amy Johnston is distraught and readily admits that she is “grasping at straws.” Diagnosed last year with pancreatic…
SScience Read More Why a synthetic human genome is still worth buildingJune 4, 2026 Ten years ago, when I was a first-year graduate student, my PhD adviser smuggled me into a private…
SScience Read More Towards mRNA therapeutics 2.0 | Nature Reviews Drug DiscoveryJune 3, 2026 Kallen, K.-J. et al. A novel, disruptive vaccination technology: self-adjuvanted RNActive® vaccines. Hum. Vaccin. Immunother. 9, 2263–2276 (2013). Article …
BBusiness Read More CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill FoundayoMay 28, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…